Tag: <span>ebolavirus vaccine</span>

From the Editor-in-Chief: The Biotech Industry Continues to Improve

It appears that the state of the biotech industry continues to improve. We now have a licensed cellular therapy that Dendreon developed, and which has now been sold to another firm that thinks it can make and administer this prostate cancer vaccine more efficiently, plus provide a more effective product. There is also a viral gene vector that has been licensed in Europe, and an application for US licensing has been submitted. Then there is the licensed influenza vaccine that is made with baculovirus technology, plus a second baculovirus-derived flu vaccine that is near licensure. The two companies with these flu vaccines are now charging ahead with their baculovirus expertise to produce Ebola vaccines…

Read MoreFrom the Editor-in-Chief: The Biotech Industry Continues to Improve

Biologics Production

autologous cellular vaccine baculovirus expression biologics bioproduction biosimilars cancer vaccines cellular therapies cryoprotectant ebolavirus vaccine immunogenicity m&a mergers and acquisitions viral gene vectors

Rapid Manufacture and Release of a GMP Batch of Zaire Ebolavirus Glycoprotein Vaccine Made Using Recombinant Baculovirus-Sf9 Insect Cell Culture Technology

For the ongoing 2014 Ebola virus outbreak, all viable options and technologies need to be evaluated as potential countermeasures to address this emerging biological threat. Novavax, Inc. has a rapid, practical vaccine development and manufacturing platform with the capability to deliver clinical trial material and, ultimately, commercial doses in response to novel infectious disease agents. This report describes the application of our platform technology for the successful generation, manufacture, and release of a clinical batch of Zaire ebolavirus glycoprotein nanoparticle vaccine three months from project initiation…

Read MoreRapid Manufacture and Release of a GMP Batch of Zaire Ebolavirus Glycoprotein Vaccine Made Using Recombinant Baculovirus-Sf9 Insect Cell Culture Technology

Baculovirus Expression Technology Biologics Biologics Production Cell Lines Manufacturing Quality Risk Management (QRM) Regulatory Vaccines

ebolavirus vaccine glycoprotein glycoprotein vaccine gp2 micelle nanoparticle nanoparticle vaccine sf9 baculovirus Spodoptera frugiperda Zaire ebolavirus